Genetic Technologies Limited [ASX:GTG] share price and news 2022

Company Description

Genetic Technologies Limited (GTG) is diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women’s health. The Company’s lead products are GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products.

Genetic Technologies Limited belongs to Health Care sector and under industry of Life Sciences Tools & Services. You can get more information about this company via their website: http://www.gtglabs.com.

This a small cap company with market cap of 81 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 5.29 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how gtg dividend grows in the recent years.

No data